Search results
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Colorado Springs Gazette· 6 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization recommendations and comes after the agency's advisers on Wednesday overwhelmingly backed the ...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
CNBC· 4 days agoThe biotech company is the first to release positive phase three data on a Covid and flu combination shot, giving it a potential lead over rival vaccine ...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoAnd Moderna stock surged more than 9% on Dec. 19, the day it released the news. Moderna also...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 5 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 7 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...